$RBRK

Wassenaar Yvonne sold $58K of RBRK

Wassenaar Yvonne sold 721 shares of Rubrik, Inc. (RBRK) at $80.73 on 2026-06-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Wassenaar Yvonne
Published Jun 4, 2026, 1:41 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 4, 2026, 2:03 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$RBRK
Neutral
medium confidence
Mentioned
$RBRK
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RBRKNeutralLow
01

Why it matters

The disclosure provides transparency on insider activity but does not introduce a new operational/financial catalyst for Rubrik.

02

Market read

For traders, this is primarily a sentiment/positioning datapoint rather than a fundamental driver.

03

What to watch

The sale size is relatively small and the plan is pre-arranged, so the market may discount it unless paired with other negative company-specific news.

Relevance 6/10Novelty 3/10Timing: Filed/dated June 3, 2026 (after-hours disclosure window)

Background

SEC Form 4 reports insider transactions (director/officer/10% owners). This one is an open-market sale executed under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$RBRKNeutralMedium confidence
Context

Rubrik director Wassenaar Yvonne sold 721 shares in an open-market transaction under a pre-arranged 10b5-1 plan, disclosed via Form 4.

Expected impact

Likely limited near-term impact; any effect is more about sentiment/positioning than fundamentals.

Evidence & confidence

The filing is a routine Form 4 with a small value (~$58k) and explicitly states a pre-arranged 10b5-1 plan, which often dampens interpretive weight.

Market effects

No clear sector read-through from a single director’s small 10b5-1 sale.

None.

None.

Counterpoint

Even with 10b5-1, repeated insider selling can coincide with internal caution; traders may still watch for follow-on sales.

Key entities

  • Rubrik, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Wassenaar Yvonne

    Director who sold 721 shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$RBRKMed

Here's How Rubrik Stock Gained 28.6% Last Month

Rubrik (RBRK) rose 28.6% in August 2026, driven by a cybersecurity rally and strong earnings. Q2 2027 earnings showed a profit of $0.20 per share and 41% revenue growth. The stock trades at 12.7x sales and 68x free cash flow, with analysts calling the post-earnings drop a buying opportunity. The company's growth and market position make it appealing despite its high valuation and volatility.

$RBRKMed

Jim Cramer on Rubrik (RBRK): “It Just Came in Maybe Too Hot”

Rubrik, Inc. (RBRK) reported Q2 fiscal 2027 revenue of $427.3M, up 38% YoY, beating estimates. EPS was $0.20, above consensus. Subscription ARR rose 33% to $1.66B. Guidance was raised. Despite strong results, shares dropped 13% post-earnings, possibly due to high expectations. Free cash flow grew 14% YoY, but margins declined. Hedge fund holdings decreased slightly, and short interest is around 9%.

$RBRKMed

Rubrik’s AI Security Bet Could Power the Next Leg Higher

Rubrik reported Q2 earnings with adjusted EPS of $0.20, beating estimates by $0.16. Revenue and earnings guidance exceeded expectations. Analysts raised price targets, with a consensus near pre-release highs. Institutional investors have been accumulating shares. Risks include high valuation and competition, notably from Microsoft. The company expects GAAP profitability by 2028.